Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study is to characterize the AggreGuide ADP Assay's performance.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ADP Blockers | platelet aggregation in response to antiplatelet drugs |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| platelet aggregation measurement | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Platelet Activity Index (PAI) | PAI at baseline and after taking ADP blocking antiplatelet drugs. | 1 week |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
community sample
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Edward Teitel, MD | Unafilliated | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Juno Research | Houston | Texas | 77036 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010974 | Platelet Aggregation |
| ID | Term |
|---|---|
| D018056 | Hemorheology |
| D001790 | Blood Physiological Phenomena |
| D002943 | Circulatory and Respiratory Physiological Phenomena |
| D015539 | Platelet Activation |
Not provided
Not provided
Not provided
Not provided
Not provided
| D006487 | Hemostasis |